Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Rong

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Statistics in Medicine|May 3, 2017
Pattern mixture models for clinical validation of biomarkers in the presence of missing dataFei Gao, Jun Dong, Donglin Zeng, et al.
Journal of Biopharmaceutical Statistics|February 14, 2018
Biomarker threshold adaptive designs for survival endpointsGuoqing Diao, Jun Dong, Donglin Zeng, et al.
Journal of Biopharmaceutical Statistics|March 16, 2017
Statistical design of noninferiority multiple region clinical trials to assess global and consistent treatment effectsGuoqing Diao, Donglin Zeng, Joseph G Ibrahim, et al.
Cancer Treatment Reviews|July 30, 2015
Extended RAS analysis for anti-epidermal growth factor therapy in patients with metastatic colorectal cancerJ Randolph Hecht, Jean-Yves Douillard, Lee Schwartzberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2010
Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancerMarc Peeters, Timothy Jay Price, Andrés Cervantes, et al.
The New England Journal of Medicine|September 13, 2013
Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancerJean-Yves Douillard, Kelly S Oliner, Salvatore Siena, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Statistics in Medicine|May 3, 2017
Pattern mixture models for clinical validation of biomarkers in the presence of missing dataFei Gao, Jun Dong, Donglin Zeng, et al.
Journal of Biopharmaceutical Statistics|February 14, 2018
Biomarker threshold adaptive designs for survival endpointsGuoqing Diao, Jun Dong, Donglin Zeng, et al.
Journal of Biopharmaceutical Statistics|March 16, 2017
Statistical design of noninferiority multiple region clinical trials to assess global and consistent treatment effectsGuoqing Diao, Donglin Zeng, Joseph G Ibrahim, et al.
Cancer Treatment Reviews|July 30, 2015
Extended RAS analysis for anti-epidermal growth factor therapy in patients with metastatic colorectal cancerJ Randolph Hecht, Jean-Yves Douillard, Lee Schwartzberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2010
Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancerMarc Peeters, Timothy Jay Price, Andrés Cervantes, et al.
The New England Journal of Medicine|September 13, 2013
Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancerJean-Yves Douillard, Kelly S Oliner, Salvatore Siena, et al.
Pageof 2